EV/EBITDA:
-25.85+0.12(+0.46%)Summary
- As of today, AXSM EV/EBITDA is -25.85, with a rise of +0.12 (+0.46%) during the most recent trading session on October 13, 2025.
- Over the past year, AXSM EV/EBITDA has dropped by -12.10 (-88.00%).
- AXSM EV/EBITDA is now -1888.46% below its all-time high of -1.30.
Performance
AXSM EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
AXSM EV/EBITDA Trends
PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise ValueEnterprise Value | PricePrice |
---|---|---|---|
1D1 Day | +0.5% | -0.5% | -0.5% |
1M1 Month | -2.3% | +2.3% | +2.3% |
3M3 Months | -11.5% | +11.5% | +11.2% |
6M6 Months | -43.0% | +26.0% | +23.6% |
YTDYTD | -76.0% | +49.0% | +43.2% |
1Y1 Year | -88.0% | +45.3% | +38.4% |
5Y5 Years | +6.0% | +123.6% | +60.3% |
AXSM EV/EBITDA Highs & Lows
PeriodPeriod | HighHigh | Current vs Highvs High | LowLow | Current vs Lowvs Low | |
---|---|---|---|---|---|
1M | 1-Month | -24.32 | -6.3% | -26.14 | +1.1% |
3M | 3-Month | -21.36 | -21.0% | -27.61 | +6.4% |
6M | 6-Month | -18.08 | -43.0% | -27.61 | +6.4% |
1Y | 1-Year | -13.31 | -94.2% | -27.61 | +6.4% |
3Y | 3-Year | -10.43 | -147.8% | -27.61 | +6.4% |
5Y | 5-Year | -6.04 | -328.0% | -31.70 | +18.4% |
All-Time | All-Time | -1.30 | -1888.5% | -74.77 | +65.4% |
AXSM EV/EBITDA History
Date | Value |
---|---|
2025 | -25.85(-76.0%) |
2024 | -14.69(+7.4%) |
2023 | -15.86(+14.5%) |
2022 | -18.54(-64.9%) |
2021 | -11.24(+61.3%) |
Date | Value |
---|---|
2020 | -29.04(+46.2%) |
2019 | -53.94(-1966.7%) |
2018 | -2.61(+39.4%) |
2017 | -4.31(-13.7%) |
2016 | -3.79(+66.2%) |
2015 | -11.21 |
FAQ
- What is Axsome Therapeutics, Inc. EV/EBITDA?
- What is the all-time high EV/EBITDA for Axsome Therapeutics, Inc.?
- What is AXSM EV/EBITDA year-to-date change?
- What is Axsome Therapeutics, Inc. EV/EBITDA year-on-year change?
What is Axsome Therapeutics, Inc. EV/EBITDA?
The current EV/EBITDA of AXSM is -25.85
What is the all-time high EV/EBITDA for Axsome Therapeutics, Inc.?
Axsome Therapeutics, Inc. all-time high EV/EBITDA is -1.30
What is AXSM EV/EBITDA year-to-date change?
Axsome Therapeutics, Inc. EV/EBITDA has changed by -11.16 (-75.97%) since the beginning of the year
What is Axsome Therapeutics, Inc. EV/EBITDA year-on-year change?
Over the past year, AXSM EV/EBITDA has changed by -12.10 (-88.00%)